Navigation Links
Biochemical and Molecular Engineering XVII Conference
Date:12/20/2010

Started in 1978, the Biochemical Engineering Conference is the premier venue for unveiling research at the cutting-edge of biological sciences and engineering. The primary goal of this international conference has always been to bring together academic and industrial scientists and engineers from diverse backgrounds to share insights on how to tackle critical problems in biochemical, biomedical and biomolecular engineering. As it enters its fourth decade, BME XVII will showcase progress in emerging frontiers at the forefront of major societal needs. The venue for the meeting will be the beautiful Bell Harbor Conference Center in the heart of Seattle, Washington.

Keynote Presentations
Dr. Doug Cameron, Alberti Advisors LLC
Biochemical Engineering and the Re-emerging Bio-based Chemical Industry
Professor David Baker, University of Washington
Design of Folding, Binding and Catalysis

A highlight of the conference will be the two keynote presentations from Dr. Doug Cameron of Alberti Advisors LLC and Prof. David Baker of the University of Washington. Doug Cameron is the Founder and Managing Director at Alberti Advisors LLC and is a prominent scientist, businessman and thought leader in the areas of clean technology and sustainable agriculture. His career has spanned business, finance and academia, including stints at Khosla Ventures, Piper Jaffray, Cargill, Stanford University and the University of Wisconsin, Madison. In 2009, Doug was the recipient of the prestigious Raphael Katzen Award for his contributions in furthering the deployment and commercialization of biotechnology to produce fuels and chemicals from renewable resources. David Baker is an HMMI Investigator and Professor in the University of Washington. He pioneered the Rosetta protein structure modeling platform and harnessed the computing power of Rosetta@home to make significant advances in protein-structure prediction and design. Baker won the AAAS Newcomb Cleveland Prize in 2005 for engineering the novel protein fold Top7. He recently created "Foldit," a multiplayer online protein-folding game.

Conference Chairs

Franois Baneyx
University of Washington
baneyx@uw.edu
Phone +1-206-685-7659

Costas Maranas
Penn State University
costas@psu.edu
Phone +1-814-863-9958

Beth Junker
Merck & Company
beth.junker@merck.com
Phone +1-732-594-7010

Session Information

    Biomolecular Engineering of Biofuels and Commodity Chemicals
    Novel Strategies for Biologics Production
    Bioremediation Approaches for the 21st Century
    The Bio-Nano Interface
    Design of Biomolecular Structures
    Biomolecular Networks (In honor of Prof. Mike Shuler)
    Biomolecular Solutions for Health
    Cell Differentiation Engineering
    Engineering Effective Vaccines
    Rethinking Process Scale-Up
    Technologies for Accelerating Cell Culture Development
    Conference Support for Academic Researchers & Graduate Students

Depending on the level of external support, conference organizers will provide financial assistance to some academic researchers, graduate students, and post-docs whose abstracts are accepted for presentation. Participants who receive financial assistance are expected to attend the entire conference.

Conference Attendance

Attendance will be limited and by invitation only. For effective interactions of all participants, the conference will be limited to 250 attendees. Invitation will be based on conference participation through chairing a session, poster or oral presentation or other contributions to the conference

If you would like an invitation to attend, please complete and return the electronic Application as soon as possible and no later than February 15, 2011. No more applications will be accepted once the conference is full.

Publication of Abstracts

Abstracts of presentations will be published in the conference program, available to all participants at the time of the conference.

Conference Venue

The conference will be held at the Bell Harbor International Conference Center in Seattle, Washington (www.bellharbor.com). Located on the waterfront in Seattle, Washington, Bell Harbor International Conference Center offers 100,000 square feet of conference, meeting and special event space featuring 180-degree panoramic views of the Olympic Mountains, Mt. Rainier, Puget Sound's Elliott Bay and the Seattle skyline.

Conference Hotel

Participants will stay at the Seattle Marriott Waterfront Hotel, just a couple of minutes walk from the Bell Harbor Conference Center (www.marriott.com/hotels/travel/seawf-seattle-marriott-waterfront/). The hotel is located in the heart of downtown Seattle's most popular waterfront district. Many of the hotel's luxury guestrooms feature private balconies offering breathtaking views of Mt. Rainier, Elliott Bay or the Olympic Mountain range. The hotel is also just steps away from the famous Pike Place Market, and only minutes to major attractions and shopping.


'/>"/>

Contact: Kevin Korpics
kevin@engconfintl.org
Engineering Conferences International
Source:Eurekalert

Related medicine news :

1. NutriLuxe Offers Personal, At-Home Body Biochemical Balance Test
2. Personalized molecular therapy shows promising results for people with advanced lung cancer
3. Researchers identify a molecular switch that controls neuronal migration in the developing brain
4. SNM sharpens focus on molecular imaging innovation and translation
5. Molecular playbook for halting heart failure risk factor uncovered
6. Synthetic lethality strategy improves molecularly targeted cancer therapy
7. Scientists identify molecular gatekeeper of arthritis
8. Personalized medicine: Molecular imaging predicts treatment success in many cancers
9. Molecular imaging identifies high-risk patients with heart disease
10. Researchers develop magnetic molecular machines to deliver drugs to unhealthy cells
11. New diagnostic chip able to generate single-cell molecular fingerprints for brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... Islandia, NY (PRWEB) , ... December 08, 2016 ... ... company, is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture ... published in JMIR Medical Informatics . , Results of the comparative usability ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Center has been recognized for adherence to the highest standards of trauma, ... accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among ...
(Date:12/8/2016)... ... 2016 , ... Vida Health, the digital health platform that pairs ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect ... consumers who are managing chronic conditions or simply want to improve their ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: